Furthermore, miR-203 inhibited BIRC5 (SURVIVIN) and RASAL2 expression (Supplementary Figure 1), thus confirming its suppressor activity for HCC [19, 20]. The gene discussed is BIRC5; the disease is hepatocellular carcinoma.